Black Diamond Therapeutics, Inc.
BDTX
$3.05
$0.113.74%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 142.83M | 152.40M | 98.58M | 112.68M | 122.97M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.90M | 3.28M | 2.60M | 2.86M | 3.78M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 146.73M | 155.68M | 101.18M | 115.54M | 126.75M |
|
|||||
Total Current Assets | 146.73M | 155.68M | 101.18M | 115.54M | 126.75M |
Net Property, Plant & Equipment | 18.67M | 19.54M | 20.40M | 21.24M | 22.07M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 985.00K | 1.03M | 1.07M | 1.12M | 1.16M |
Total Assets | 166.39M | 176.25M | 122.64M | 137.90M | 149.99M |
|
|||||
Total Accounts Payable | 771.00K | 2.63M | 4.01M | 1.97M | 763.00K |
Total Accrued Expenses | 12.25M | 10.51M | 13.16M | 15.50M | 14.42M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.78M | 3.71M | 3.40M | 3.33M | 3.26M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 16.81M | 16.85M | 20.57M | 20.80M | 18.44M |
|
|||||
Total Current Liabilities | 16.81M | 16.85M | 20.57M | 20.80M | 18.44M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 16.97M | 17.88M | 18.78M | 19.67M | 20.53M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 33.78M | 34.73M | 39.36M | 40.47M | 38.97M |
|
|||||
Common Stock & APIC | 573.76M | 572.10M | 570.37M | 568.44M | 566.70M |
Retained Earnings | -441.13M | -430.57M | -487.11M | -471.12M | -455.57M |
Treasury Stock & Other | -25.00K | -19.00K | 24.00K | 107.00K | -115.00K |
Total Common Equity | 132.61M | 141.52M | 83.29M | 97.43M | 111.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 132.61M | 141.52M | 83.29M | 97.43M | 111.02M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 132.61M | 141.52M | 83.29M | 97.43M | 111.02M |
|